相关实验视频

Updated: Jul 27, 2026

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
08:44

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice

Published on: April 19, 2020

10.4K

确定POLD1作为肝细胞癌的潜在预后和免疫治疗生物标志物

Weiwei Liu1, Chengcheng Huang2, Chaoqun Wang2

  • 1Department of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University, 83 Xinqiao Main Street, Chongqing, 400000, PR China; Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Nanchang University,1 Mindle Road, Nanchang, Jiangxi, 330006, PR China.

International journal of biological macromolecules
|September 29, 2025
PubMed
概括

研究人员确定了DNA聚合酶delta 1催化子单元 (POLD1) 作为肝细胞癌 (HCC) 发展中的关键基因. 这一发现为进展性肝癌提供了潜在的新诊断和治疗点.

关键词:
DNA聚合酶delta1的催化子单元肝细胞癌是肝细胞癌.免疫治疗生物标志物胰腺癌分析分析预测生物标志物预测生物标志物

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.9K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...